IDYA
Ideaya Biosciences Inc
NASDAQ: IDYA · HEALTHCARE · BIOTECHNOLOGY
$28.05
-3.41% today
Updated 2026-04-29
Market cap
$2.46B
P/E ratio
—
P/S ratio
11.26x
EPS (TTM)
$-1.28
Dividend yield
—
52W range
$17 – $39
Volume
1.3M
WallStSmart proprietary scores
35
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A9.0
Quality
A+2.0
Profitability
F6.7
Valuation
B4/9
Piotroski F-Score
Moderate
6.6
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$52.81
+88.27%
12-Month target
—
—
Intrinsic (DCF)
$160.75
Margin of safety
+80.16%
3 Strong Buy13 Buy2 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 6.56 — safe zone
+ Revenue growth 55.40% QoQ
+ 80.16% below intrinsic value
+ Debt/equity 0.05x — low leverage
Risks
- Thin margins at -52.00%
- Negative free cash flow $-90.83M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $50.93M | $23.39M | $7.00M | $218.71M | $218.71M |
| Net income | $-54.81M | $-112.96M | $-274.48M | $-113.70M | $-83.27M |
| EPS | — | — | — | — | $-1.28 |
| Free cash flow | $-90.62M | $-117.59M | $-251.44M | $-73.47M | $-90.83M |
| Profit margin | -107.61% | -483.05% | -3,921.10% | -51.99% | -52.00% |
Peer comparison
Smart narrative
Ideaya Biosciences Inc trades at $28.05. Our Smart Value Score of 35/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 6.56, it sits in the safe zone. TTM revenue stands at $218.71M. with profit margins at -52.00%. Our DCF model estimates intrinsic value at $160.75.
Frequently asked questions
What is Ideaya Biosciences Inc's stock price?
Ideaya Biosciences Inc (IDYA) trades at $28.05.
Is Ideaya Biosciences Inc overvalued?
Smart Value Score 35/100 (Grade D, Sell). DCF value $160.75.
What is the price target of Ideaya Biosciences Inc (IDYA)?
The analyst target price is $52.81, representing +88.3% upside from the current price of $28.05.
What is the intrinsic value of Ideaya Biosciences Inc (IDYA)?
Based on our DCF model, intrinsic value is $160.75, a +80.2% margin of safety versus $28.05.
What is Ideaya Biosciences Inc's revenue?
TTM revenue is $218.71M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
6.56 — safe zone.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio11.26x
ROE-10.90%
Beta0.02
50D MA$32.24
200D MA$30.33
Shares out0.09B
Float0.09B
Short ratio—
Avg volume1.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—